Dave and Scott discuss the increasing usage of CGMs among people with type 1 diabetes, emphasizing the importance of technology advancements in improving diabetes management. They highlight the impact of CGM usage on better outcomes and reflect on the significant progress made in diabetes technology over the last decade.
